Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03668717 · ClinicalTrials.gov registry record

Survivorship and Outcomes of Robotic-Arm Assisted Medial Unicompartmental Knee Arthroplasty

A clinical trial of Osteoarthritis, sponsored by St. Helena Hospital Coon Joint Replacement Institute.

Active
Registry status
133
Enrollment target
1
Study location

NCT03668717: Active study of Osteoarthritis, sponsored by St. Helena Hospital Coon Joint Replacement Institute.

NCT03668717 is a study of Osteoarthritis that is active but no longer recruiting, run by St. Helena Hospital Coon Joint Replacement Institute. The registered enrollment target is 133 participants, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03668717, a study of Osteoarthritis, is active but no longer recruiting, sponsored by St. Helena Hospital Coon Joint Replacement Institute.

ACTIVE NOT RECRUITING
Registry status
133 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to determine the survivorship of robotic-arm assisted MCK medial onlay Unicompartmental knee arthroplasty implants at two, five and tem year follow up.

Conditions Studied

Interventions

  • DEVICE Robotic-arm assisted medical MCK implant

Study Locations (1)

California

  • St. Helena Hospital Coon Joint Replacement Institute - St. Helena

Trial Details

FieldValue
Enrollment Target 133 participants
Start Date 2011-10
Est. Completion 2026-04

What the registry record for NCT03668717 still lists

NCT03668717 is an observational study that tracks outcomes without assigning an intervention. The registered 133 participants enrollment target is mid-sized for trials with a published cap, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (84% lower).

The record links to 1 condition, with Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which Robotic-arm assisted medical MCK implant is the first listed.

NCT03668717 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT03668717 about?

NCT03668717 is a clinical study titled "Survivorship and Outcomes of Robotic-Arm Assisted Medial Unicompartmental Knee Arthroplasty". The purpose of the study is to determine the survivorship of robotic-arm assisted MCK medial onlay Unicompartmental knee arthroplasty implants at two, five and tem year follow up.

What is the current status of trial NCT03668717?

This trial is currently active not recruiting. The enrollment target is 133 participants. The study started on 2011-10. Estimated completion is 2026-04.

What conditions does trial NCT03668717 study?

This clinical trial studies the following conditions: Osteoarthritis.

What interventions are being tested in trial NCT03668717?

The interventions under investigation include: Robotic-arm assisted medical MCK implant (DEVICE).

Who is sponsoring clinical trial NCT03668717?

This trial is sponsored by St. Helena Hospital Coon Joint Replacement Institute, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03668717 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03668717's enrollment target sits among peer trials

133 78th of 135 higher than 58 of 135 other Osteoarthritis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04276870 · 133 participants · Phase 2

    Orphan Indications for CD19 Redirected Autologous T Cells

  • NCT04671771 · 133 participants · NA

    A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease

  • NCT05610085 · 133 participants · Phase 2

    A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures

  • NCT06206486 · 133 participants

    The Gut Microbiome and Serum Metabolites As a Biological Mechanism Underlying Pain in Kidney Transplantation

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT03668717, the US trial registry maintained by the National Library of Medicine. NCT03668717 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.